Related Experiment Video
Updated: Jun 29, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Management of Obstructive Sleep Apnea in the Infant and Newborn
Jillian N Sanford1, Derek J Lam2
1Division of Pediatric Pulmonology and Sleep Medicine, Department of Pediatrics, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA.
Insights
Obstructive sleep apnea (OSA) in infants differs significantly from older children, lacking clear diagnostic guidelines and established treatments. Management requires personalized approaches considering unique infant anatomy and conditions.
Area of Science:
- Pediatric Pulmonology
- Sleep Medicine
- Neonatal Care
Background:
- Infant obstructive sleep apnea (OSA) presents unique physiological and etiological challenges distinct from older children.
- Current diagnostic criteria and clinical practice guidelines for infant OSA are not well-established.
- Existing literature lacks comprehensive management strategies tailored for this specific age group.
Purpose of the Study:
- To highlight the distinct characteristics of obstructive sleep apnea in newborns and infants.
- To discuss the challenges in diagnosing and interpreting polysomnography in infants.
- To emphasize the need for individualized treatment strategies for infant OSA.
Main Methods:
- Review of current literature on infant obstructive sleep apnea.
- Analysis of sleep physiology differences between infants and older children.
- Examination of common etiologies and treatment modalities for infant OSA.
Main Results:
- Infant OSA involves unique sleep physiology and diverse etiologies like laryngomalacia, micrognathia, and nasal obstruction.
- Polysomnography interpretation and indications are less defined in infants compared to adults.
- Adenotonsillar hypertrophy is also a potential cause of airway obstruction in this age group.
Conclusions:
- Treatment for infant obstructive sleep apnea necessitates a tailored, multidisciplinary approach.
- Management must consider specific patient anatomy and co-existing conditions.
- Further research is needed to establish definitive clinical practice guidelines for infant OSA.
Abstract:
Obstructive sleep apnea in newborns and infants presents a unique challenge with distinct differences in sleep physiology, etiologies, and management compared to older children. The indications for and interpretation of polysomnography are less well defined in infants. There are also no broadly accepted clinical practice guidelines for treating sleep apnea in this age group. Etiologies include general causes of upper airway obstruction in infants such as laryngomalacia, micrognathia, and nasal obstruction in addition to adenotonsillar hypertrophy. Treatment strategies must be tailored to the specific anatomic features and comorbidities of the specific patients and often require a multidisciplinary approach.
More Related Videos
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Administering Oxygen by Mask
Administering oxygen by mask is a common nursing intervention that provides supplemental oxygen to patients with respiratory distress or chronic lung conditions. This procedure involves delivering oxygen at a specified rate through a face mask connected to an oxygen source.
Equipment
The equipment necessary for this procedure includes:
Suctioning the Oropharyngeal Airway
After assembling the equipment, the nurse should practice hand hygiene and don appropriate PPE according to infection control guidelines to avoid the...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

